BALCHEM CORP

Chemicals & Allied Products

BCPC Chemicals People in Chemicals SEC CIK 0000009326 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$5.24B
31,878,021 shares Covers every share class this company has on file.
Insiders on file
12
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$35.56M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
0.68%
insider-held value divided by market capitalisation

What BALCHEM CORP reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$1.04B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
$154.85M
FY2025 profit for the period, from this company’s own annual XBRL filings to the SEC
Employees
1,379
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at BALCHEM CORP

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against BALCHEM CORP.
Insider Reported role Shares Value Last action
Officers 7
Carl Martin Bengtsson CFO 29,012 $4.98M F Shares withheld for taxes Feb 12, 2026 position reported
Michael Brent Tignor SVP 12,179 $2.09M F Shares withheld for taxes Feb 12, 2026 position reported
Job Leonard van Gunsteren Job Leonard van Gunsteren SVP 10,149 $1.74M F Shares withheld for taxes Feb 12, 2026 position reported
Martin Luther Reid Martin Luther Reid SVP 9,615 $1.65M F Shares withheld for taxes Feb 12, 2026 position reported
Frederic Boned Frederic Boned SVP 9,419 $1.62M F Shares withheld for taxes Feb 12, 2026 position reported
Hatsuki Miyata Hatsuki Miyata General Counsel 9,232 $1.58M F Shares withheld for taxes Feb 12, 2026 position reported
William A Backus Chief Accounting Officer 7,019 $1.20M F Shares withheld for taxes Feb 12, 2026 position reported
Officers who also sit on the board 2
Theodore L Harris Theodore L Harris CEO 94,403 $16.20M F Shares withheld for taxes Feb 12, 2026 position reported
Monica Vicente CFO 2,390 $410.1K A Grant or award Feb 11, 2026 position reported
Directors 3
David B Fischer Board Member 8,859 $1.52M A Grant or award Feb 11, 2026 position reported
Matthew David Wineinger Board Member 8,012 $1.37M A Grant or award Feb 11, 2026 position reported
Daniel E Knutson Board Member 6,899 $1.18M A Grant or award Feb 11, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

David B Fischer sold 8,000 BALCHEM CORP (BCPC) shares for $1,231,760 on Dec 3, 2025

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

David B Fischer sold 8,000 BALCHEM CORP (BCPC) shares for $1,231,760 on Dec 3, 2025
Date Insider Transaction Shares Price Value Filing
Dec 3, 2025 David B Fischer S Open-market sale 2,000 held after: 7,989 $154.15 $308,300 SEC filing ↗
Dec 3, 2025 David B Fischer S Open-market sale 6,000 held after: 9,989 $153.91 $923,460 SEC filing ↗

Total of the rows above: $1,231,760, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 95 rows we hold, 0 are open-market purchases and 11 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for BALCHEM CORP, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Feb 12, 2026 Frederic Boned F Shares withheld for taxes 203 $177.49 $36.0K SEC filing ↗
Feb 12, 2026 Hatsuki Miyata F Shares withheld for taxes 181 $177.49 $32.1K SEC filing ↗
Feb 12, 2026 Michael Brent Tignor F Shares withheld for taxes 165 $177.49 $29.3K SEC filing ↗
Feb 12, 2026 Martin Luther Reid F Shares withheld for taxes 116 $177.49 $20.6K SEC filing ↗
Feb 12, 2026 Job Leonard van Gunsteren F Shares withheld for taxes 58 $177.49 $10.3K SEC filing ↗
Feb 12, 2026 William A Backus F Shares withheld for taxes 70 $177.49 $12.4K SEC filing ↗
Feb 12, 2026 Carl Martin Bengtsson F Shares withheld for taxes 302 $177.49 $53.6K SEC filing ↗
Feb 12, 2026 Theodore L Harris F Shares withheld for taxes 844 $177.49 $149.8K SEC filing ↗
Feb 11, 2026 Frederic Boned F Shares withheld for taxes 1,151 $178.68 $205.7K SEC filing ↗
Feb 11, 2026 Frederic Boned A Grant or award 2,247 $0.00 $0 SEC filing ↗
Feb 11, 2026 Frederic Boned A Grant or award 2,870 $0.00 $0 SEC filing ↗
Feb 11, 2026 Hatsuki Miyata A Grant or award 1,710 $0.00 $0 SEC filing ↗
Feb 11, 2026 Hatsuki Miyata F Shares withheld for taxes 877 $178.68 $156.7K SEC filing ↗
Feb 11, 2026 Hatsuki Miyata A Grant or award 2,247 $0.00 $0 SEC filing ↗
Feb 11, 2026 Monica Vicente A Grant or award 870 $0.00 $0 SEC filing ↗
Feb 11, 2026 Michael Brent Tignor A Grant or award 1,929 $0.00 $0 SEC filing ↗
Feb 11, 2026 Michael Brent Tignor A Grant or award 1,200 $0.00 $0 SEC filing ↗
Feb 11, 2026 Michael Brent Tignor F Shares withheld for taxes 991 $178.68 $177.1K SEC filing ↗
Feb 11, 2026 Martin Luther Reid A Grant or award 2,359 $0.00 $0 SEC filing ↗
Feb 11, 2026 Martin Luther Reid F Shares withheld for taxes 1,085 $178.68 $193.9K SEC filing ↗
Feb 11, 2026 Martin Luther Reid A Grant or award 940 $0.00 $0 SEC filing ↗
Feb 11, 2026 Job Leonard van Gunsteren A Grant or award 1,345 $0.00 $0 SEC filing ↗
Feb 11, 2026 Job Leonard van Gunsteren F Shares withheld for taxes 756 $178.68 $135.1K SEC filing ↗
Feb 11, 2026 Job Leonard van Gunsteren A Grant or award 430 $0.00 $0 SEC filing ↗
Feb 11, 2026 Daniel E Knutson A Grant or award 870 $0.00 $0 SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Subsidiaries — 17 legal entities

Subsidiaries of BALCHEM CORP

17 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries BALCHEM CORP names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
Aberco, Inc. Maryland
Albion Laboratories, Inc. Nevada
Balchem BV Netherlands
Balchem Canada Corporation Canada
Balchem Italia Srl Italy
Balchem Ltd. Canada
Balchem NV Belgium
Balchem Philippines, Inc. Philippines
Balchem Pty Ltd. Australia
Balchem Sdn Bhd Malaysia
BCP Ingredients, Inc. Delaware
Kappa Bioscience AS Norway
Kappa Bioscience Europe GmbH Germany
Kappa Solutions AS Norway
Kechu BidCo AS Norway
SensoryEffects Cereal Systems, Inc. Delaware
SensoryEffects, Inc. Delaware
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from BALCHEM CORP’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from BALCHEM CORP’s own SEC filings multiplied by the closing price we hold for the same stock.